Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01370226 · ClinicalTrials.gov registry record · NA

Health Explorer - Optimizing Alcohol Brief Interventions

A NA study of Alcohol Abuse, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
750
Enrollment target
1
Study location

NCT01370226: Completed NA study of Alcohol Abuse, sponsored by University of Michigan.

NCT01370226 is a NA study of Alcohol Abuse that has completed, run by University of Michigan. The registered enrollment target is 750 participants, roughly in line with the 697-participant average among 46 other Alcohol Abuse trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01370226, a NA study of Alcohol Abuse, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
750 participants
Enrollment target
1
Study location

Study Summary

The aims of the study are to develop and refine tailored motivational brief interventions that are parallel in structure but have varied delivery modalities (computer vs. therapist) for patients with at-risk or problematic alcohol use, and to conduct a randomized controlled trial comparing the efficacy of these BI approaches (CBI, TBI, control) on subsequent alcohol consumption and alcohol consequences, including alcohol-related injury, mental and physical-health functioning, and HIV risk behaviors at 3-, 6-, and 12-months post-ED visit.

Conditions Studied

Interventions

  • BEHAVIORAL CBI
  • BEHAVIORAL TBI

Study Locations (1)

Michigan

  • University of Michigan Health System Emergency Department - Ann Arbor

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2012-01
Est. Completion 2015-12
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01370226 record still lists

NCT01370226 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 697-participant average among 46 other Alcohol Abuse trials with a reported enrollment target.

The record links to 1 condition, with Alcohol Abuse appearing as the primary indexed condition, and to 2 interventions - of which CBI is the first listed.

NCT01370226 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01370226 about?

NCT01370226 is a clinical study titled "Health Explorer - Optimizing Alcohol Brief Interventions". The aims of the study are to develop and refine tailored motivational brief interventions that are parallel in structure but have varied delivery modalities (computer vs. therapist) for patients with at-risk or problematic alcohol use, and to conduct a randomized controlled trial comparing the effic...

What is the current status of trial NCT01370226?

This trial is currently completed. It is a NA study. The enrollment target is 750 participants. The study started on 2012-01. Estimated completion is 2015-12.

What conditions does trial NCT01370226 study?

This clinical trial studies the following conditions: Alcohol Abuse.

What interventions are being tested in trial NCT01370226?

The interventions under investigation include: CBI (BEHAVIORAL), TBI (BEHAVIORAL).

Who is sponsoring clinical trial NCT01370226?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01370226 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01370226's enrollment target sits among peer trials

750 5th of 46 higher than 42 of 46 other Alcohol Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02048332 · 750 participants · Phase 1

    Donor-Derived Viral Specific T-cells (VSTs)

  • NCT02087852 · 750 participants

    Kidney Cancer DNA Registry

  • NCT02532452 · 750 participants · Phase 2

    Third Party Viral Specific T-cells (VSTs)

  • NCT03126916 · 750 participants · Phase 3

    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01370226, the US trial registry maintained by the National Library of Medicine. NCT01370226 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.